JP2022506955A5 - - Google Patents
Info
- Publication number
- JP2022506955A5 JP2022506955A5 JP2021525113A JP2021525113A JP2022506955A5 JP 2022506955 A5 JP2022506955 A5 JP 2022506955A5 JP 2021525113 A JP2021525113 A JP 2021525113A JP 2021525113 A JP2021525113 A JP 2021525113A JP 2022506955 A5 JP2022506955 A5 JP 2022506955A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid nanoparticles
- compound
- nanoparticles according
- approximately
- total lipids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862758055P | 2018-11-09 | 2018-11-09 | |
| US62/758,055 | 2018-11-09 | ||
| PCT/US2019/060595 WO2020097548A1 (en) | 2018-11-09 | 2019-11-08 | Lipid nanoparticle formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022506955A JP2022506955A (ja) | 2022-01-17 |
| JP2022506955A5 true JP2022506955A5 (cg-RX-API-DMAC7.html) | 2022-11-07 |
| JP7506670B2 JP7506670B2 (ja) | 2024-06-26 |
Family
ID=70612210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525113A Active JP7506670B2 (ja) | 2018-11-09 | 2019-11-08 | 脂質ナノ粒子製剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220001029A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3877522A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7506670B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113728101A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019377131A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3118559A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020097548A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3864163T3 (da) | 2018-10-09 | 2024-05-06 | Univ British Columbia | Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed |
| CN113286882A (zh) | 2018-11-09 | 2021-08-20 | 阿布特斯生物制药公司 | 脂质纳米颗粒制剂 |
| AU2020355000A1 (en) | 2019-09-23 | 2022-03-17 | Sepia Therapeutics, Inc. | Compositions and methods for modulating apolipoprotein B (APOB) gene expression |
| CN114729376A (zh) | 2019-09-23 | 2022-07-08 | 欧米茄治疗公司 | 用于调节肝细胞核因子4α(HNF4α)基因表达的组合物和方法 |
| WO2021183720A1 (en) | 2020-03-11 | 2021-09-16 | Omega Therapeutics, Inc. | Compositions and methods for modulating forkhead box p3 (foxp3) gene expression |
| AU2021252164B2 (en) | 2020-04-09 | 2026-07-02 | Finncure Oy | Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses |
| US12194157B2 (en) | 2020-04-09 | 2025-01-14 | Finncure Oy | Carrier for targeted delivery to a host |
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| MX2023004371A (es) | 2020-10-14 | 2023-07-26 | George Mason Res Foundation Inc | Lípidos ionizables, y métodos de fabricación y uso de los mismos. |
| CN112980878B (zh) * | 2021-02-04 | 2023-03-31 | 中国农业科学院兰州兽医研究所 | Hdac8基因敲除的bhk-21细胞系及其构建方法和应用 |
| CN112877275B (zh) * | 2021-02-04 | 2023-03-31 | 中国农业科学院兰州兽医研究所 | Hdac2基因敲除的bhk-21细胞系及其构建方法和应用 |
| WO2023283359A2 (en) | 2021-07-07 | 2023-01-12 | Omega Therapeutics, Inc. | Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| KR20230053998A (ko) | 2021-10-15 | 2023-04-24 | (주)지노믹트리 | mRNA 발현을 위한 유전자 구조체 |
| CN118804743A (zh) * | 2022-03-04 | 2024-10-18 | 益杰立科(上海)生物科技有限公司 | 靶向递送系统和方法 |
| US20260077037A1 (en) * | 2022-07-04 | 2026-03-19 | Bharat Biotech International Limited | Cationic lipid based composition, formulation and use for nucleic acid vaccine delivery and preparation thereof |
| EP4716741A2 (en) | 2023-05-23 | 2026-04-01 | Flagship Labs 114, Inc. | Compositions and methods for reducing cxcl9, cxcl10, and cxcl11 gene expression |
| EP4722368A1 (en) | 2023-05-26 | 2026-04-08 | Samsung Biologics Co., Ltd. | Novel nucleic acid construct comprising poly(a) tail having secondary or tertiary structure and uses thereof |
| KR20250018367A (ko) | 2023-07-28 | 2025-02-05 | 한국과학기술원 | 히스톤 코드 리더 도메인을 포함하는 폴리펩티드 및 이의 용도 |
| KR20250064736A (ko) | 2023-11-02 | 2025-05-12 | (주)지노믹트리 | 방광암 예방 또는 치료용 조성물 |
| AU2024409925A1 (en) | 2023-12-26 | 2026-08-06 | Emmune, Inc. | Systems for nucleic acid transfer |
| AU2025217182A1 (en) | 2024-02-02 | 2026-08-06 | Editas Medicine, Inc. | MODIFIED GUIDE RNAs |
| WO2025210520A1 (en) * | 2024-04-04 | 2025-10-09 | Genevant Sciences Gmbh | Lipid nanoparticles for inducing an immunological response |
| WO2025213138A1 (en) | 2024-04-05 | 2025-10-09 | Editas Medicine, Inc. | Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma |
| WO2025264646A2 (en) * | 2024-06-17 | 2025-12-26 | The Board Of Regents Of The University Of Texas System | Direct in vivo gene editing of lung stem cells for durable therapy of genetic lung disease |
| CN121265551A (zh) * | 2024-07-02 | 2026-01-06 | 苏州星核迪赛生物技术有限公司 | 一种靶向肝实质细胞的核酸递送载体及其应用 |
| WO2026102260A1 (en) | 2024-11-08 | 2026-05-15 | Editas Medicine, Inc. | Crispr-related methods and compositions targeting angiopoietin like 3 (angptl3) |
| CN120037202B (zh) * | 2025-01-14 | 2025-12-26 | 浙江大学 | 一种基于连接处含有分支结构的阳离子脂质的脂质纳米颗粒及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2621480B1 (en) * | 2010-09-30 | 2018-08-15 | Sirna Therapeutics, Inc. | Low molecular weight cationic lipids for oligonucleotide delivery |
| WO2012054365A2 (en) * | 2010-10-21 | 2012-04-26 | Merck Sharp & Dohme Corp. | Novel low molecular weight cationic lipids for oligonucleotide delivery |
| US9126966B2 (en) | 2011-08-31 | 2015-09-08 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods of use thereof |
| US9352042B2 (en) | 2012-02-24 | 2016-05-31 | Protiva Biotherapeutics, Inc. | Trialkyl cationic lipids and methods of use thereof |
| WO2013158579A1 (en) * | 2012-04-19 | 2013-10-24 | Merck Sharp & Dohme Corp. | Novel diester and triester based low molecular weight, biodegradable cationic lipids for oligonucleotide delivery |
| WO2015011633A1 (en) * | 2013-07-23 | 2015-01-29 | Protiva Biotherapeutics, Inc. | Compositions and methods for delivering messenger rna |
| US10415037B2 (en) * | 2014-10-02 | 2019-09-17 | Arbutus Biopharma Corporation | Compositions and methods for silencing hepatitis B virus gene expression |
| AU2017379901B2 (en) | 2016-12-21 | 2024-02-15 | Arbutus Biopharma Corporation | Methods for ameliorating infusion reactions |
| CN113286882A (zh) * | 2018-11-09 | 2021-08-20 | 阿布特斯生物制药公司 | 脂质纳米颗粒制剂 |
-
2019
- 2019-11-08 CA CA3118559A patent/CA3118559A1/en active Pending
- 2019-11-08 US US17/291,960 patent/US20220001029A1/en not_active Abandoned
- 2019-11-08 WO PCT/US2019/060595 patent/WO2020097548A1/en not_active Ceased
- 2019-11-08 JP JP2021525113A patent/JP7506670B2/ja active Active
- 2019-11-08 CN CN201980088382.9A patent/CN113728101A/zh active Pending
- 2019-11-08 EP EP19882056.5A patent/EP3877522A4/en not_active Withdrawn
- 2019-11-08 AU AU2019377131A patent/AU2019377131A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022506956A5 (cg-RX-API-DMAC7.html) | ||
| JP7822173B2 (ja) | アルギニノコハク酸合成酵素欠損症のmRNA治療 | |
| CN106795096B (zh) | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 | |
| US12285462B2 (en) | pH-triggered membrane peptide-mediated epitope tethering at cell surfaces | |
| JP2022530018A5 (cg-RX-API-DMAC7.html) | ||
| CN107922364B (zh) | 用于递送核酸的脂质和脂质纳米颗粒制剂 | |
| JP2024518375A5 (cg-RX-API-DMAC7.html) | ||
| CN107208095B (zh) | 用于使乙型肝炎病毒基因表达沉默的组合物和方法 | |
| US12351834B2 (en) | Compositions and methods for the treatment of ornithine transcarbamylase deficiency | |
| JP7752615B2 (ja) | メッセンジャーrnaの直腸送達 | |
| Huang et al. | An mTOR siRNA‐loaded spermidine/DNA tetrahedron nanoplatform with a synergistic anti‐inflammatory effect on acute lung injury | |
| JP2017536092A5 (cg-RX-API-DMAC7.html) | ||
| JP2020532546A (ja) | 組織特異的送達用のカチオン性脂質組成物 | |
| CN103845317A (zh) | 恩他卡朋在预防或治疗肥胖等代谢综合征中的应用 | |
| KR20230087536A (ko) | Mrna-로딩된 지질 나노입자를 제조하는 개선된 프로세스 | |
| EP3908597A1 (en) | Composition and methods for treatment of primary ciliary dyskinesia | |
| Chen et al. | Aminoguanidine-assembled functional DNA tetrahedron alleviates acute lung injury by targeting the cGAS-STING signaling pathway | |
| ES2331835T3 (es) | Oligonucleotidos antisentido capaces de inhibir la formacion de tubos capilares. | |
| CN120754284B (zh) | 一种用于肝脏靶向联合递送CRISPR-Cas9系统和单链DNA修复模板的脂质纳米颗粒 | |
| EP4267181B1 (en) | Nucleic acid stabilizing solution for vaccines, therapy, diagnostics, storage, and transport | |
| US20110081403A1 (en) | Histone octamers for increased nucleic acid transfer | |
| US20220220189A1 (en) | Compositions and methods for treatment of hemochromatosis | |
| US20220370354A1 (en) | Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia | |
| JP2025521244A (ja) | イオン化可能な脂質およびそれを含むナノ粒子 | |
| CN119818705B (zh) | 一种mRNA组合物及其应用 |